JP2025500784A5 - - Google Patents
Info
- Publication number
- JP2025500784A5 JP2025500784A5 JP2024534144A JP2024534144A JP2025500784A5 JP 2025500784 A5 JP2025500784 A5 JP 2025500784A5 JP 2024534144 A JP2024534144 A JP 2024534144A JP 2024534144 A JP2024534144 A JP 2024534144A JP 2025500784 A5 JP2025500784 A5 JP 2025500784A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- antibody
- seq
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163287557P | 2021-12-09 | 2021-12-09 | |
| US63/287,557 | 2021-12-09 | ||
| US202163290765P | 2021-12-17 | 2021-12-17 | |
| US63/290,765 | 2021-12-17 | ||
| PCT/IB2022/061991 WO2023105479A1 (en) | 2021-12-09 | 2022-12-09 | Use of amivantamab to treat colorectal cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025500784A JP2025500784A (ja) | 2025-01-15 |
| JP2025500784A5 true JP2025500784A5 (cg-RX-API-DMAC7.html) | 2025-12-12 |
Family
ID=84537874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024534144A Pending JP2025500784A (ja) | 2021-12-09 | 2022-12-09 | 結腸直腸癌を治療するためのアミバンタマブの使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20230183360A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4444426A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025500784A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240112963A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022407875A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3241933A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL313410A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024007066A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023105479A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202547867A (zh) * | 2024-01-16 | 2025-12-16 | 美商健生生物科技公司 | 使用阿米維單抗治療結腸直腸癌 |
| WO2026022733A1 (en) * | 2024-07-23 | 2026-01-29 | Janssen Biotech, Inc. | Combination therapies for the treatment of colorectal cancer |
| WO2026022739A1 (en) * | 2024-07-23 | 2026-01-29 | Janssen Biotech, Inc. | Combination therapies for the treatment of colorectal cancer |
| WO2026150367A1 (en) * | 2025-01-13 | 2026-07-16 | Janssen Biotech, Inc. | Bispecific anti-egfr/c-met antibody-drug conjugates |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0281604B1 (en) | 1986-09-02 | 1993-03-31 | Enzon Labs Inc. | Single polypeptide chain binding molecules |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| ATE199392T1 (de) | 1992-12-04 | 2001-03-15 | Medical Res Council | Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung |
| AUPO591797A0 (en) | 1997-03-27 | 1997-04-24 | Commonwealth Scientific And Industrial Research Organisation | High avidity polyvalent and polyspecific reagents |
| WO2006028936A2 (en) | 2004-09-02 | 2006-03-16 | Genentech, Inc. | Heteromultimeric molecules |
| KR101374454B1 (ko) | 2005-03-31 | 2014-03-17 | 추가이 세이야쿠 가부시키가이샤 | 회합제어에 의한 폴리펩티드 제조방법 |
| DE102005028778A1 (de) | 2005-06-22 | 2006-12-28 | SUNJÜT Deutschland GmbH | Mehrlagige Folie mit einer Barriere- und einer antistatischen Lage |
| DK1999154T3 (da) | 2006-03-24 | 2012-12-03 | Merck Patent Gmbh | Fremstillede heterodimere proteindomæner |
| WO2007147901A1 (en) | 2006-06-22 | 2007-12-27 | Novo Nordisk A/S | Production of bispecific antibodies |
| CN101952312A (zh) | 2007-07-31 | 2011-01-19 | 米迪缪尼有限公司 | 多特异性表位结合蛋白及其应用 |
| AU2008343589A1 (en) | 2007-12-19 | 2009-07-09 | Centocor Ortho Biotech Inc. | Design and generation of human de novo pIX phage display libraries via fusion to pIX or pVII, vectors, antibodies and methods |
| US20090162359A1 (en) | 2007-12-21 | 2009-06-25 | Christian Klein | Bivalent, bispecific antibodies |
| US8227577B2 (en) | 2007-12-21 | 2012-07-24 | Hoffman-La Roche Inc. | Bivalent, bispecific antibodies |
| US8242247B2 (en) | 2007-12-21 | 2012-08-14 | Hoffmann-La Roche Inc. | Bivalent, bispecific antibodies |
| US9266967B2 (en) | 2007-12-21 | 2016-02-23 | Hoffmann-La Roche, Inc. | Bivalent, bispecific antibodies |
| US9067986B2 (en) | 2009-04-27 | 2015-06-30 | Oncomed Pharmaceuticals, Inc. | Method for making heteromultimeric molecules |
| PT2560993T (pt) | 2010-04-20 | 2024-09-16 | Genmab As | Proteínas contendo anticorpo heterodimérico fc e métodos para a produção das mesmas |
| CN103429620B (zh) | 2010-11-05 | 2018-03-06 | 酵活有限公司 | 在Fc结构域中具有突变的稳定异源二聚的抗体设计 |
| US9574010B2 (en) | 2011-11-04 | 2017-02-21 | Zymeworks Inc. | Stable heterodimeric antibody design with mutations in the Fc domain |
| KR102373193B1 (ko) * | 2012-11-21 | 2022-03-10 | 얀센 바이오테크 인코포레이티드 | 이중특이성 EGFR/c-Met 항체 |
| MX2021010265A (es) * | 2019-02-26 | 2021-09-23 | Janssen Biotech Inc | Terapias de combinacion y estratificacion de pacientes con anticuerpos anti-egfr/c-met biespecificos. |
| BR112022015140A2 (pt) * | 2020-02-12 | 2022-10-11 | Janssen Biotech Inc | Tratamento de pacientes que têm mutações de salto do éxon 14 de c-met |
-
2022
- 2022-12-08 US US18/077,318 patent/US20230183360A1/en not_active Abandoned
- 2022-12-09 MX MX2024007066A patent/MX2024007066A/es unknown
- 2022-12-09 IL IL313410A patent/IL313410A/en unknown
- 2022-12-09 EP EP22826446.1A patent/EP4444426A1/en active Pending
- 2022-12-09 AU AU2022407875A patent/AU2022407875A1/en active Pending
- 2022-12-09 KR KR1020247022472A patent/KR20240112963A/ko active Pending
- 2022-12-09 CA CA3241933A patent/CA3241933A1/en active Pending
- 2022-12-09 WO PCT/IB2022/061991 patent/WO2023105479A1/en not_active Ceased
- 2022-12-09 JP JP2024534144A patent/JP2025500784A/ja active Pending
-
2025
- 2025-01-17 US US19/028,911 patent/US20250257139A1/en active Pending